Genprex, Inc. (GNPX)
NASDAQ: GNPX · Real-Time Price · USD
2.950
+0.150 (5.36%)
Nov 25, 2025, 4:00 PM EST - Market closed
Genprex Market Cap
Genprex has a market cap or net worth of $4.81 million as of November 25, 2025. Its market cap has decreased by -13.69% in one year.
Market Cap
4.81M
Enterprise Value
3.71M
1-Year Change
-13.69%
Ranking
Category
Stock Price
$2.95
Market Cap Chart
Since March 29, 2018, Genprex's market cap has decreased from $61.25M to $4.81M, a decrease of -92.14%. That is a compound annual growth rate of -28.24%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 25, 2025 | 4.81M | -33.56% |
| Dec 31, 2024 | 7.25M | -47.00% |
| Dec 29, 2023 | 13.67M | -80.37% |
| Dec 30, 2022 | 69.63M | 11.19% |
| Dec 31, 2021 | 62.63M | -64.95% |
| Dec 31, 2020 | 178.67M | 2,798.61% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Mar 29, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 948.84B |
| Johnson & Johnson | 491.26B |
| AbbVie | 417.60B |
| UnitedHealth Group | 289.84B |
| AstraZeneca | 280.49B |
| Novartis AG | 243.93B |
| Merck & Co. | 242.64B |
| Abbott Laboratories | 222.77B |